Radu VADANICI

En résumé

Entreprises

• Bristol-Myers Squibb - Disease Area Specialist Immunoscience

  Rueil-Malmaison cedex 2015 - maintenant

• DOCS - Medical project manager

  2015 - 2015 Disease area specialist, Rheumatoid Arthritis

• Sanofi - Senior Project Leader, Global Product Development

  Paris 2010 - 2012 Managed new product developments projects for international OTC brands such as Allegra®, Magne® B6, from conception up to final prototypes delivery

• Sanofi-aventis group - Marketing Director Europe

  Paris 2009 - 2010 - Maximized Arava® (leflunomide) revenue after data protection expiry in Europe Region, double digit growth maintained for the following years
  - Evaluated business potential for 10 partnering & licensing opportunities
  

• Sanofi-aventis group - Marketing Director Europe Region, Arava

  Paris 2005 - 2008 - Elaborated Arava® strategic marketing efforts for the Europe region
  - Achieved sales double digit yearly growth rate, turnover reached 108M€ by 2008 (P&L responsibilities, budget >1 M€, over 300 headcounts involved in Arava® operations)
  - Ensured coordination with the Latin America, Canada, Australia and Japan regions
  - Led company investment and scientific operations during international events such as EULAR Congress
  - Able to timely respond to EMEA health authorities challenges on safety brand profile (2006) by implementing a risk minimization plan for all European countries
  - Led development of an innovative patient compliance programme, aiming at addressing rheumatoid arthritis patients' needs (Arrive on-line® initiative, 5 languages)
  - Established partnerships with most important rheumatoid arthritis patient associations
  - Drove development for a new HPLC dosage method with top laboratories

• Sanofi-aventis - Marketing Director, Arava®, Actonel®, Romania

  Paris 2004 - 2005 - Led team growth and post merger integration
  - Gain 40% market share for Actonel® and enlarged market access for Arava®

• Aventis - Business Unit Manager, Rheumatoid Arthritis & Osteoporosis

  Paris 2002 - 2004 - Arava® market share in units reached 26%, EU average 7%
  - Drove Actonel® market access via fast procedure in 2003
  - Led business transition required to support Arava® success and Actonel® launch

• Aventis - Brand Manager Arava®

  Paris 2000 - 2002 - Drive Arava® market access process in a very restrictive context

• Aventis - Medical Advisor Oncology

  Paris 1998 - 2000 - Maximized Taxotere® market penetration, managed Campto® launch-
  - Achieved outstanding business results on local market, 4x fold sales increase

• Rhone poulenc rorer - Medical Advisor Hospital, Clexane®/Lovenox®

  1997 - 1997 - National brand champion twice.

• GP's office - General Practitioner

  1995 - 1996

• District Hospital Brasov - M.D.

  1994 - 1995

Formations

• Kennesaw State University (Atlanta)

  Atlanta 2002 - 2004 Master of Business Administration
  
  Business economics

• University Of Medicine (Cluj Napoca)

  Cluj Napoca 1987 - 1993 M.D

Réseau

• Ben Haj Ali IMEN

• Cyrille SIDAWY

• Daniela KOPCZUK

• David MALLEVAL

• Fahri BEN FREDJ

• Lassaad BEN ARBIA

• Nicolas MALARTRE

• Pascal DENGEL

• Radouene LITIM